Opportunity Information: Apply for CDC RFA GH11 1165
Apply for CDC RFA GH11 1165
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Enhanced Surveillance in the Republic of Uganda under the President s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Mar 1, 2011 and posted on Mar 1, 2011.
- Applicants must submit their applications by Apr 28, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $4,875,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 4 candidate(s).
- Eligible applicants include: County governments Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments State governments Native American tribal governments (Federally recognized) Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses Public and State controlled institutions of higher education City or township governments.
- Eligible applicants that can apply for this funding opportunity are Nonprofit with 501C3 IRS status (other than institution of higher education) Nonprofit without 501C3 IRS status (other than institution of higher education) For profit organizations (other than small business) Small, minority, and women owned businesses Universities Colleges Research institutions Hospitals Community based organizations Faith based organizations Federally recognized or state recognized American Indian/Alaska Native tribal governments American Indian/Alaska native tribally designated organizations Alaska Native health corporations Urban Indian health organizations Tribal epidemiology centers State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) Political subdivisions of States (in consultation with States) Non domestic (non U.S.) entity Other (specify) A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a letter from the state or local government as documentation of the status is required. Attach with Other Attachment Forms when submitting via www.grants.gov.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Centers for Disease Control and Prevention (CDC) funding opportunity CDC RFA GH11-1165, titled "Enhanced Surveillance in the Republic of Uganda under the President's Emergency Plan for AIDS Relief (PEPFAR)," was a discretionary cooperative agreement program designed to strengthen disease surveillance and applied public health research in Uganda, with a strong emphasis on HIV and HIV-related health priorities. The overarching intent was to generate higher-quality, actionable data on infectious diseases affecting Ugandan populations and to ensure that the evidence collected is actively used to improve real-world prevention, care, and control programs. By structuring the award as a cooperative agreement, CDC signaled that recipients should expect substantial federal involvement and technical collaboration rather than a hands-off grant relationship.
The program goals centered on two connected tracks. First, it aimed to support field surveys, routine and enhanced surveillance activities, and laboratory-based studies focused on important human infectious diseases in Uganda. While HIV was the central priority under PEPFAR, the scope was intentionally broad and included sero-behavioral surveillance (linking biological testing with behavioral risk information) and clinical care surveillance, especially among populations considered most-at-risk or high-risk. Priority HIV program areas explicitly included prevention of mother-to-child transmission (PMTCT), voluntary counseling and testing (VCT), and related maternal and child health work. The opportunity also recognized the need for integrated infectious disease intelligence beyond HIV alone, listing neglected tropical diseases, sexually transmitted infections (STIs), tuberculosis, and malaria as key areas for surveillance and study. In practical terms, this points to investments in study design and implementation, specimen collection and testing capacity, data systems, and analytic work that can describe disease burden, risk patterns, service coverage, and outcomes across different regions and populations.
Second, the program emphasized moving from data collection to program impact. Applicants were expected not only to produce surveillance findings, but to incorporate results into operational health promotion, disease prevention, and disease control activities in Uganda. This includes translating findings into decisions about targeting, resource allocation, intervention design, and performance improvement for ongoing public health programs. A major expectation was knowledge sharing and capacity building: recipients were to help ensure that expertise and surveillance outputs were shared with Ugandan government entities and also disseminated to other countries, non-governmental organizations, and academic institutions. That focus implies deliverables like reports, briefs, presentations, shared methodologies, training or mentorship, and potentially collaborative platforms that make surveillance information usable and comparable across partners.
In terms of funding structure and scale, the opportunity was posted March 1, 2011, with an original and final closing date of April 28, 2011, and an archive date of May 28, 2011. CDC anticipated making up to four awards, with an estimated total funding level of $4,875,000. The listing did not specify an award ceiling or floor, which often indicates that final award sizes could vary based on the proposed scope, geographic coverage, and negotiated workplans under the cooperative agreement framework. There was no cost sharing or matching requirement, reducing barriers for applicants that might not have substantial non-federal resources.
Eligibility was broad and inclusive, reflecting an intent to attract capable implementers across government, academia, and the private and nonprofit sectors. Eligible applicants included nonprofits with and without 501(c)(3) status, public and private institutions of higher education, hospitals, research institutions, community-based and faith-based organizations, for-profit organizations (including those other than small businesses), and small, minority-, and women-owned businesses. Government eligibility included state and local governments and their bona fide agents, as well as tribal governments and tribally designated health organizations. Importantly for an international public health surveillance effort, non-U.S. (non-domestic) entities were also listed as eligible, which would allow Uganda-based or other international organizations with appropriate capacity to apply. For applicants submitting as a bona fide agent of a state or local government, a formal letter documenting that status was required as part of the application package.
Administratively, the opportunity fell under CFDA 93.067 (Global AIDS) and the funding activity category of Health. The additional information note indicated that applicants would need to consult the full announcement text for complete requirements and instructions, and CDC provided the Procurement and Grants Office Technical Information Management Section contact number (770-488-2700) for assistance accessing the full announcement. Taken together, the grant opportunity can be understood as an effort to strengthen Uganda's evidence base for HIV and other priority infectious diseases, improve the quality and reach of surveillance systems and laboratory-supported studies, and ensure that findings feed directly into programs and are shared broadly to maximize public health impact.
Frequently Asked Questions (FAQs)
1) What is CDC RFA GH11-1165?
CDC RFA GH11-1165 is a CDC funding opportunity titled "Enhanced Surveillance in the Republic of Uganda under the President's Emergency Plan for AIDS Relief (PEPFAR)." It was offered as a discretionary cooperative agreement to strengthen disease surveillance and applied public health research in Uganda, with a strong emphasis on HIV and HIV-related priorities.
2) What is the main purpose of this funding opportunity?
The main purpose is to produce higher-quality, actionable infectious disease data in Uganda and ensure the evidence is actively used to improve real-world prevention, care, and disease control programs. The program is designed to improve both surveillance quality and the practical use of surveillance findings in program decision-making.
3) What does it mean that this is a cooperative agreement?
Because the award mechanism is a cooperative agreement, recipients should expect substantial federal involvement from CDC, including technical collaboration, rather than a fully hands-off grant relationship.
4) What countries or geographic areas are the focus of the program?
The program focus is the Republic of Uganda.
5) What are the program goals or major tracks of work?
The opportunity describes two connected tracks:
- Supporting field surveys, routine and enhanced surveillance, and laboratory-based studies focused on important human infectious diseases in Uganda (with HIV as the central priority under PEPFAR).
- Ensuring surveillance findings are translated into operational health promotion, disease prevention, and disease control activities, including sharing knowledge and building capacity among Ugandan entities and other partners.
6) What types of activities are supported under the surveillance and research track?
Supported activities include field surveys, routine surveillance, enhanced surveillance activities, and laboratory-based studies. The opportunity also points to practical investments such as study design and implementation, specimen collection and testing capacity, data systems, and analytic work to describe disease burden, risk patterns, service coverage, and outcomes across regions and populations.
7) Is HIV the only disease area covered?
No. While HIV is the central priority under PEPFAR, the scope is intentionally broader. The opportunity also highlights neglected tropical diseases, sexually transmitted infections (STIs), tuberculosis, and malaria as key areas for surveillance and study.
8) What specific HIV-related program areas are explicitly mentioned?
The opportunity explicitly mentions prevention of mother-to-child transmission (PMTCT), voluntary counseling and testing (VCT), and related maternal and child health work as priority HIV program areas.
9) What is meant by sero-behavioral surveillance?
Sero-behavioral surveillance is described as linking biological testing (sero- or other laboratory testing) with behavioral risk information to better understand risk patterns and disease transmission dynamics.
10) Does the opportunity emphasize specific populations?
Yes. The announcement highlights surveillance efforts, including clinical care surveillance, especially among populations considered most-at-risk or high-risk.
11) Beyond collecting data, what else were applicants expected to do?
Applicants were expected to move from data collection to program impact. That includes incorporating surveillance results into decisions about targeting, resource allocation, intervention design, and performance improvement for ongoing public health programs in Uganda.
12) What does the opportunity say about dissemination and knowledge sharing?
Recipients were expected to share expertise and surveillance outputs with Ugandan government entities and disseminate information to other countries, non-governmental organizations, and academic institutions. This implies deliverables such as reports, briefs, presentations, shared methodologies, and training or mentorship activities that make surveillance information usable across partners.
13) When was this funding opportunity posted and when did it close?
It was posted on March 1, 2011. The original and final closing date was April 28, 2011. The archive date was May 28, 2011.
14) How many awards did CDC anticipate making?
CDC anticipated making up to four awards.
15) What was the estimated total funding amount?
The estimated total funding level was $4,875,000.
16) Was an award ceiling or floor specified?
No. The listing did not specify an award ceiling or floor. This suggests award sizes could vary depending on proposed scope, geographic coverage, and negotiated workplans under the cooperative agreement framework.
17) Was cost sharing or matching required?
No. The opportunity stated there was no cost sharing or matching requirement.
18) Who was eligible to apply?
Eligibility was broad and included:
- Nonprofits with and without 501(c)(3) status
- Public and private institutions of higher education
- Hospitals and research institutions
- Community-based and faith-based organizations
- For-profit organizations (including those other than small businesses)
- Small, minority-, and women-owned businesses
- State and local governments and their bona fide agents
- Tribal governments and tribally designated health organizations
- Non-U.S. (non-domestic) entities
19) Are non-U.S. (non-domestic) organizations eligible?
Yes. Non-U.S. (non-domestic) entities were listed as eligible, which would allow Uganda-based or other international organizations with appropriate capacity to apply.
20) What documentation is required if applying as a bona fide agent of a state or local government?
If an applicant submits as a bona fide agent of a state or local government, a formal letter documenting that status is required as part of the application package.
21) What is the CFDA number associated with this opportunity?
The opportunity is under CFDA 93.067 (Global AIDS).
22) What is the funding activity category?
The funding activity category is Health.
23) Where can applicants find complete requirements and instructions?
The note in the listing indicates applicants would need to consult the full announcement text for complete requirements and instructions.
24) Who can be contacted for help accessing the full announcement?
CDC provided the Procurement and Grants Office Technical Information Management Section contact number: 770-488-2700.
25) What kinds of outcomes was CDC trying to achieve in Uganda through this opportunity?
Based on the description, CDC aimed to strengthen Uganda's evidence base for HIV and other priority infectious diseases by improving surveillance systems and laboratory-supported studies, increasing the quality and usefulness of data, and ensuring findings are translated into improved prevention, care, and control programs and shared broadly to maximize public health impact.
Browse more opportunities from the same category: Health
Next opportunity: Formative Assessment of HIV Risk and Size Estimation Among Most At Risk Populations (MARPs) and Integrated Biological and Behavioral Surveillance Among MARPs in the Republic of Zambia under the President s Emergency Plan for AIDS Relief (PEPFAR)
Previous opportunity: Emerging Infections Sentinel Network (EISN)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH11 1165
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH11 1165) also looked into and applied for these:
| Funding Opportunity |
|---|
| Formative Assessment of HIV Risk and Size Estimation Among Most At Risk Populations (MARPs) and Integrated Biological and Behavioral Surveillance Among MARPs in the Republic of Zambia under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1169 Funding Number: CDC RFA GH11 1169 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,103,500 |
| Strengthening the Capacity of the Dominican Republic to Provide HIV/STI/TB Prevention and Risk Reduction Among Drug Users under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1172 Funding Number: CDC RFA GH11 1172 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Demographic Surveillance Study Support in the Republic of Mozambique under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 11101 Funding Number: CDC RFA GH11 11101 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Technical Assistance To The Ministry Of Health (MOH) For HIV Services And Program Transition In The Republic Of Mozambique Under The President s Emergency Plan For AIDS Relief (PEPFAR) Apply for CDC RFA GH11 11108 Funding Number: CDC RFA GH11 11108 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Cooperative Agreement with the Direction Nationale de lEau Potable et de lAssainissement (DINEPA) Apply for CDC RFA GH11 11105 Funding Number: CDC RFA GH11 11105 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Limited Competition Revision for Resuscitation Outcomes Center Randomized Clinical Trial (U01) Apply for RFA HL 11 036 Funding Number: RFA HL 11 036 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Sustaining Influenza Surveillance Networks and Response to Seasonal and Pandemic Influenza by National Health Authorities outside the United States Apply for CDC RFA IP11 1103 Funding Number: CDC RFA IP11 1103 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Morris K. Udall Centers of Excellence for Parkinsons Disease Research (P50) Apply for RFA NS 11 004 Funding Number: RFA NS 11 004 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| FY 2011 Cooperative Agreements for the National Suicide Prevention Lifeline Crisis Center Follow Up Apply for SM 11 004 Funding Number: SM 11 004 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $360,000 |
| Strengthening the Capacity of Local Indigenous Faith Based Partners in Zambia to Provide HIV/AIDS Prevention, Treatment and Care Services in a Comprehensive and Sustainable Manner under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1120 Funding Number: CDC RFA GH11 1120 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Partnerships for Biodefense (R01) Apply for RFA AI 11 014 Funding Number: RFA AI 11 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Economics of Retirement (R01) Apply for PA 11 138 Funding Number: PA 11 138 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Economics of Retirement (R03) Apply for PA 11 139 Funding Number: PA 11 139 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Economics of Retirement (R21) Apply for PA 11 140 Funding Number: PA 11 140 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Cooperative Agreement with the South Africa National Health Laboratory Service (NHLS) Apply for CDC RFA GH11 1199 Funding Number: CDC RFA GH11 1199 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Part D Coordinated HIV Services and Access to Research for WICY One Time Supplemental Funds Apply for HRSA 11 094 Funding Number: HRSA 11 094 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Affordable Care Act Program for Early Detection of Certain Medical Conditions Related to Environmental Health Hazards Apply for CDC RFA TS11 1102PPHF11 Funding Number: CDC RFA TS11 1102PPHF11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,500,000 |
| Competitive Revision Applications for NIDCR funded Cooperative Agreements (U01) Apply for PAR 11 144 Funding Number: PAR 11 144 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research Centers for Excellence in Clinical Preventive Services (P01) Apply for RFA HS 11 005 Funding Number: RFA HS 11 005 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| The Infant Immune System Implications for Vaccines and Response to Infections (R01) Apply for RFA AI 11 010 Funding Number: RFA AI 11 010 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH11 1165", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.